Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Phase 1
Recruiting
- Conditions
- Head and Neck CarcinomaAdenoid Cystic CarcinomaLung CancerNon-Small Cell Lung CancerBreast CancerPancreatic CancerMesotheliomaThymic CarcinomaCervical CancerOvarian Cancer
- Interventions
- First Posted Date
- 2018-06-14
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- VM Oncology, LLC
- Target Recruit Count
- 82
- Registration Number
- NCT03556228
- Locations
- 🇺🇸
Holy Cross Hospital (site 213), Fort Lauderdale, Florida, United States
🇺🇸Providence Medical Foundation (site 209), Santa Rosa, California, United States
🇺🇸Hartford Hospital (site 210), Hartford, Connecticut, United States
News
No news found